Weight Loss Medication | Scottsdale Weight Loss

Facts on Prescription Weight Loss Medications

Posted: Aug 30 in Our Blog by

The goal of prescription weight loss medications is to help an individual lose weight. Medical weight loss with the use of medication is generally intended to help people who haven’t been able to lose weight through exercise and diet, even after multiple attempts. Before selecting a weight management medication for you, your Mesa doctor will examine your medical history, your previous weight loss efforts, and current body mass index (BMI). Once prescribed, you’ll still be advised to eat a healthy diet and exercise regularly in order to encourage weight loss.

Tagged: | Comments: None

FDA Bans Weight Loss Drug Contrave

Posted: Feb 28 in Our Blog by

The FDA has banned the weight loss drug Contrave, arguing that it poses a risk to health. Although two ingredients in Contrave, bupropion and naltexone, are already in use, the FDA decision to ban Contrave is based on its potential risks to the heart, outweighing its benefits in treating obesity. With the rapid rise in [...]

Tagged: | Comments: None

Prescription Weight Loss Drugs

Posted: Feb 13 in Our Blog by

In addition to diet and exercise, your weight loss doctor may prescribe certain types of medications to help you lose weight. Learn more about the types of prescription weight loss medications available, how they work, and who should consider taking them.

Tagged: | Comments: one response

Weight Loss Drug Warning: Meridia (Sibutramine) gets a new warning

Posted: Jan 19 in Our Blog by

Meridia, also known as sibutramine, was released in the 1990s, as a weight loss medication. Since the beginning, we have known that it often increases blood pressure and pulse that is persistent despite further weight loss.

Tagged: | Comments: None

Qnexa — New Weight Loss Drug for Obesity

Posted: Sep 15 in Our Blog by

At a medical conference a few years ago, a physician discussed (only briefly) a new drug in the pipeline for weight loss. At that time, all that was really said was that it was a combination of phentermine and topiramate.

Tagged: , , | Comments: None

Obesity Costs

Posted: Jul 15 in Our Blog by

Recently, the Wall Street Journal, ran an article about the cost and expense associated with being overweight. As the number of obese persons increased by 37% between 1998 and 2006, the medical expenses for treating those who are about 30 or more pounds overweight increased to about 9.

Tagged: | Comments: None

Acomplia won’t make it to US

Posted: Oct 27 in Our Blog by

In October, Acomplia (Rimonabant), the endocannabinoid receptor antagonist was removed from the European market. Reports of depression and suicidal thoughts have prevented FDA approval of the med.

Tagged: , | Comments: None